Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-02 Sale | 2024-04-03 4:27 pm | NVIDIA CORP | NVDA | PERRY MARK L Director | 7,000 | $887.89 | $6,215,259 | 131,612 (Indirect Direct) | View |
| 2024-02-23 Sale | 2024-02-27 5:06 pm | NVIDIA CORP | NVDA | PERRY MARK L Director | 15,000 | $796.45 | $11,946,692 | 138,612 (Indirect Direct) | View |
| 2023-02-27 Sale | 2023-02-28 4:59 pm | NVIDIA CORP | NVDA | PERRY MARK L Director | 20,000 | $236.37 | $4,727,428 | 152,962 (Indirect Direct) | View |
| 2022-03-18 Sale | 2022-03-21 6:16 pm | NVIDIA CORP | NVDA | PERRY MARK L Director | 16,716 | $263.8 | $4,409,699 | 171,524 (Indirect Direct) | View |
| 2021-04-05 Sale | 2021-04-06 4:55 pm | NVIDIA CORP | NVDA | PERRY MARK L Director | 6,104 | $556.58 | $3,397,360 | 46,631 (Indirect Direct) | View |
| 2020-05-27 Sale | 2020-05-29 6:29 pm | NVIDIA CORP | NVDA | PERRY MARK L Director | 12,208 | $333.31 | $4,069,049 | 52,023 (Indirect Direct) | View |
| 2020-05-12 Sale | 2020-05-13 6:07 pm | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 53,600 | $78.1 | $4,186,061 | 26,428 (Direct) | View |
| 2020-02-18 Sale | 2020-02-20 5:59 pm | NVIDIA CORP | NVDA | PERRY MARK L Director | 8,752 | $292.13 | $2,556,747 | 64,231 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-23 Option Award | 2023-06-27 6:24 pm | N/A N/A | NVIDIA CORP | NVDA | PERRY MARK L Director | 650 | $0 | 153,612 (Direct) | View |
| 2023-05-26 Gift | 2023-05-31 5:15 pm | N/A N/A | NVIDIA CORP | NVDA | PERRY MARK L Director | 3,000 | $0 | 13,962 (Indirect) | View |
| 2022-10-05 Disposition | 2022-10-06 4:21 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 80,412 | $0 | 0 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 6:38 pm | N/A 2032-06-13 | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 9,200 | $0 | 47,065 (Direct) | View |
| 2022-06-14 Exercise | 2022-06-16 6:38 pm | 2022-06-14 N/A | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 3,600 | $0 | 47,065 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 6:16 pm | N/A N/A | NVIDIA CORP | NVDA | PERRY MARK L Director | 1,438 | $0 | 172,962 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:27 pm | N/A 2031-06-16 | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 9,200 | $0 | 43,465 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 4:27 pm | 2021-06-17 N/A | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 3,037 | $0 | 43,465 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 4:10 pm | N/A N/A | NVIDIA CORP | NVDA | PERRY MARK L Director | 429 | $0 | 47,060 (Direct) | View |
| 2020-11-17 Equity Swap | 2020-11-19 8:19 pm | N/A N/A | MyoKardia Inc. | MYOK | PERRY MARK L Director | 29,508 | $0 | 0 (Direct) | View |
| 2020-11-17 Disposition | 2020-11-19 8:19 pm | N/A N/A | MyoKardia Inc. | MYOK | PERRY MARK L Director | 64,400 | $0 | 0 (Direct) | View |
| 2020-06-13 Exercise(A) | 2020-06-23 6:25 pm | N/A N/A | MyoKardia Inc. | MYOK | PERRY MARK L Director | 2,300 | $0 | 27,708 (Direct) | View |
| 2020-06-18 Option Award | 2020-06-22 6:59 pm | N/A 2030-06-17 | MyoKardia Inc. | MYOK | PERRY MARK L Director | 4,800 | $0 | 4,800 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 9:33 pm | N/A 2030-06-16 | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 8,284 | $0 | 39,512 (Direct) | View |
| 2020-06-17 Exercise | 2020-06-19 9:33 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 4,800 | $0 | 39,512 (Direct) | View |
| 2020-06-13 Exercise | 2020-06-16 6:03 pm | N/A N/A | MyoKardia Inc. | MYOK | PERRY MARK L Director | 2,300 | $0 | 27,708 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:21 pm | N/A N/A | NVIDIA CORP | NVDA | PERRY MARK L Director | 712 | $0 | 52,735 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-13 6:07 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 15,000 | $28.45 | 26,428 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-13 6:07 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 23,600 | $20 | 26,428 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-13 6:07 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 15,000 | $18.85 | 26,428 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-13 6:07 pm | N/A 2025-08-10 | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 53,600 | $0 | 26,428 (Direct) | View |
| 2019-06-18 Option Award | 2019-06-20 4:01 pm | N/A 2029-06-17 | Global Blood Therapeutics Inc. | GBT | PERRY MARK L Director | 12,300 | $0 | 12,300 (Direct) | View |
| 2019-06-13 Option Award | 2019-06-17 7:01 pm | N/A 2029-06-12 | MyoKardia Inc | MYOK | PERRY MARK L Director | 8,900 | $0 | 8,900 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 6:26 pm | N/A N/A | NVIDIA CORP | NVDA | PERRY MARK L Director | 1,258 | $0 | 72,983 (Direct) | View |